Table 2 WPAI of MPM patients, stratified by current treatment and current line of therapy at data abstraction, for five EU countries (combined data)
From: Malignant pleural mesothelioma: treatment patterns and humanistic burden of disease in Europe
Current treatment | Current line of therapy | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Doublet | Triplet | Singlet chemotherapy as 1 L-M | Singlet chemotherapy as SACT | Other treatments | BSC | 1-L | 1-L M | 2 L + SACT | BSC | ||
Total number of patients with completed PSC who are currently employed | 107 | 62 | 3 | 14 | 13 | 12 | 3 | 70 | 17 | 17 | 3 |
WPAI Absenteeism | |||||||||||
n | 75 | 40 | 2 | 11 | 10 | 9 | 3 | 45 | 14 | 13 | 3 |
Mean (SD), % | 36.7 (38.5) | 24.9 (33.3) | 39.9 (22.1) | 57.4 (41.3) | 35.2 (40.0) | 61.6 (41.8) | 45.9 (47.0) | 25.0 (32.1) | 49.9 (42.0) | 60.8 (41.5) | 45.9 (47.0) |
Missing | 32 | 22 | 1 | 3 | 3 | 3 | 0 | 25 | 3 | 4 | 0 |
WPAI Presenteeism | |||||||||||
n | 83 | 54 | 3 | 8 | 10 | 6 | 2 | 61 | 11 | 9 | 2 |
Mean (SD), % | 47.6 (25.5) | 47.0 (27.2) | 50.0 (17.3) | 50.0 (20.0) | 44.0 (29.5) | 50.0 (17.9) | 60.0 (28.3) | 47.2 (26.5) | 48.2 (20.4) | 46.7 (27.4) | 60.0 (28.3) |
Missing | 24 | 8 | 0 | 6 | 3 | 6 | 1 | 9 | 6 | 8 | 1 |
WPAI Overall Impairment | |||||||||||
n | 58 | 35 | 2 | 6 | 8 | 5 | 2 | 40 | 9 | 7 | 2 |
Mean (SD), % | 47.4 (24.1) | 43.2 (22.6) | 64.6 (24.9) | 54.1 (14.2) | 43.3 (31.8) | 60.1 (28.8) | 68.5 (20.3) | 44.6 (23.4) | 52.8 (21.3) | 50.7 (32.0) | 68.5 (20.3) |
Missing | 49 | 27 | 1 | 8 | 5 | 7 | 1 | 30 | 8 | 10 | 1 |
Total number with completed PSC | 767 | 399 | 29 | 89 | 97 | 59 | 94 | 475 | 102 | 96 | 94 |
WPAI Activity Impairment | |||||||||||
n | 737 | 384 | 27 | 84 | 93 | 55 | 94 | 457 | 93 | 93 | 94 |
Mean (SD), % | 56.0 (23.2) | 54.1 (21.4) | 49.3 (25.6) | 50.8 (21.2) | 60.2 (28.0) | 64.5 (23.9) | 61.2 (23.8) | 55.2 (22.8) | 51.2 (21.3) | 59.6 (25.8) | 61.2 (23.8) |
Missing | 30 | 15 | 2 | 5 | 4 | 4 | 0 | 0 | 9 | 3 | 0 |